In Vivo Effects of Myeloablative Alkylator Therapy on Survival and Differentiation of MGMTP140K-Transduced Human G-CSF-Mobilized Peripheral Blood Cells
Open Access
- 1 May 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (5) , 1016-1026
- https://doi.org/10.1016/j.ymthe.2005.11.017
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- DNA Repair Defects in Stem Cell Function and AgingAnnual Review of Medicine, 2005
- Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4Molecular Therapy, 2004
- In VivoSelection of Human Hematopoietic Cells in a Xenograft Model Using Combined Pharmacologic and Genetic ManipulationsHuman Gene Therapy, 2003
- Methylguanine methyltransferase–mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal modelJournal of Clinical Investigation, 2003
- In vivo selection of MGMT(P140K) lentivirus–transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioningJournal of Clinical Investigation, 2003
- Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expressionMolecular Therapy, 2003
- Gene therapy to protect haematopoietic cells from cytotoxic cancer drugsNature Reviews Cancer, 2002
- Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant GliomaJournal of Clinical Oncology, 2002
- Clinical Relevance of MGMT in the Treatment of CancerJournal of Clinical Oncology, 2002
- Protection and in Vivo Selection of Hematopoietic Stem Cells Using Temozolomide, O6-Benzylguanine, and an Alkyltransferase-Expressing Retroviral VectorMolecular Therapy, 2001